Bioelectronics could lead to a new class of medicine

Jul 02, 2014

Imagine having tiny electronics implanted somewhere in your body that can regulate nerve signals and make symptoms of various disorders go away. That's the vision of the field of bioelectronic medicine—the emerging discipline that has made enough promising advances to draw a big investment by a pharmaceutical giant, according to an article in Chemical & Engineering News (C&EN), the weekly news magazine of the American Chemical Society.

Ann M. Thayer, a senior correspondent at C&EN, explains that much of the progress made in bioelectronic medicine has been driven by university research so far. But more than a year ago, the British drug company GlaxoSmithKline dove into the field and is now funding about 25 investigations exploring disease biology and neural signaling. They are betting that the budding discipline will lead to a whole new class of medicines for metabolic, immune-inflammatory, respiratory, cardiovascular and other disorders.

Others are also heavily invested in the future of bioelectronic science. A few start-ups are working toward clinical applications. The National Institutes of Health is also advancing neuroscience with its Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative. But scientists still have to work out some major puzzles before they can benefit patients. For one, they have to completely map out which nerves affect which organs and functions. Once that base is built, the field could be well poised to take off.

Explore further: On the road to improvement: EPA's troubled program on chemical hazards

More information: Shock Therapy, cen.acs.org/articles/92/i26/Shock-Therapy.html

Related Stories

Personalized medicine has finally arrived—or has it?

Feb 26, 2014

As the price for decoding a person's DNA keeps dropping, expectations for personalized medicine based on specific genetic profiling rise. But translating an individual's genetic data into finely tailored medical treatments ...

Pharma firms turn attention to hearing loss

Apr 09, 2014

Hearing loss affects 36 million Americans to some degree, often leaving them feeling isolated, but it has received little attention from the pharmaceutical industry—until now. Small firms have brought a handful of potential ...

Recommended for you

Tiny silicone spheres come out of the mist

4 hours ago

Technology in common household humidifiers could enable the next wave of high-tech medical imaging and targeted medicine, thanks to a new method for making tiny silicone microspheres developed by chemists ...

Inkjet printing process for kesterite solar cells

6 hours ago

A research team at HZB has developed an inkjet printing technology to produce kesterite thin film absorbers (CZTSSe). Based on the inkjet-printed absorbers, solar cells with total area conversion efficiency ...

The next step in DNA computing: GPS mapping?

8 hours ago

Conventional silicon-based computing, which has advanced by leaps and bounds in recent decades, is pushing against its practical limits. DNA computing could help take the digital era to the next level. Scientists ...

Thermometer-like device could help diagnose heart attacks

8 hours ago

Diagnosing a heart attack can require multiple tests using expensive equipment. But not everyone has access to such techniques, especially in remote or low-income areas. Now scientists have developed a simple, ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.